Leviticus Cardio Awarded R&D Grant from BIRD Foundation

Editor’s note: News of this announcement appeared in Israel21c, No Camels, PRNewswire, and The Times of Israel.

Leviticus Cardio, inventors of the versatile transcutaneous Coplanar Energy Transfer (CET) system, together with Jarvik Heart, a global leader in left ventricular assist devices (LVAD), have been awarded a $950,000 grant from the Israel-U.S. Binational Industrial Research and Development (BIRD) Foundation.

The grant will help fund the ongoing development of a fully implanted wireless VAD system which utilizes Jarvik Heart’s pump together with Leviticus’ CET technology. It will help thousands of patients with severe heart failure live longer and with a better quality of life.

BIRD’s funding will be integrated into the first, $2.9 million, phase of the project, designed to reach clinical regulatory trials for the hybrid system.

This comes on the heels of a highly successful long-term multi-animal trial that extended over 6 months.